On 22 October 2018, the U.S. Federal Trade Commission approved the merger between Praxair and Linde subject to divestments which the final approval needed from competition authorities for the transaction to close. The transaction had previously been approved by the European Commission on 20 August 2018 subject to commitments and also gained clearance in several other jurisdictions in Asia, Middle East and South America.

A CRA Europe team advised the Parties during the proceedings in several jurisdictions worldwide. For more on this case, see here.